Parkinson Society Canada was proud to welcome the world to Montreal in early October. The week began with the inaugural World Parkinson Congress Policy Forum. The gathering was focused and intimate, with approximately 50 delegates attending including government policy staff from Canada, France, Mexico and the United States. Also in attendance were leaders from international Parkinson societies, Parkinson ambassadors, and representatives from industry. The event was moderated by Jeffery Simpson, National Affairs Columnist for The Globe and Mail. These discussions helped elevate Parkinson’s and other neurodegenerative diseases as a worldwide health issue, by examining the social and economic impact of these conditions on a global scale. A full report on the outcomes of the forum will be published shortly.
The Parkinson’s community also welcomed two public policy wins this fall. First, the issue of Genetic Fairness for Canadians took a big leap forward when it was featured in the Throne Speech as a new priority for the Government of Canada. Following on the heels of this victory, the government also finalized the Comprehensive Economic and Trade Agreement (CETA) which included reforms to intellectual property standards for medicines in Canada. Parkinson Society Canada believes these changes will provide an exciting opportunity to position this country as a world leader in advanced medical research. We believe these reforms will attract global investment in life science research in Canada, allow citizens to gain access to newer medicines, create a stronger healthcare system, and increase the quality of life of all Canadians. For more information on these and other advocacy issues, please visit our advocacy centre of the national website.